Pipeline: New Residential Treatment Centers for Teens; SSM Opens Mental Health Urgent Care

Evolve Treatment Centers opens two new locations 

Evolve Treatment Centers has opened two new residential treatment centers for teens. Both centers are located in the East Bay, with one in Walnut Creek, California, and the other in Lafayette, California.

Los Angeles-based Evolve has 13 locations across the state of California. It specializes in treating teens ages 12 to 17 and offers four main levels of care: intensive outpatient, residential, day treatment and detox. 

SSM Health opens behavioral health urgent care

SSM Health — a health system with locations in Missouri, Wisconsin, Oklahoma and Illinois — has opened a new behavioral health urgent care in Saint Louis, where the organization is headquartered.


The facility, which is located next to SSM’s DePaul Hospital behavioral health outpatient clinic, will treat patients with chronic mental illnesses, such as bipolar disorder, schizophrenia, depression and anxiety. It will also help those struggling with substance use disorder (SUD).

The goal is to keep behavioral health patients out of emergency rooms and get them better care in a more appropriate setting.

The urgent care will partner with local community health centers to get patients the follow up care they need, in addition to the services delivered by the clinic. It will accept patients with and without insurance. 


Cordant Health Solutions enters new state

Cordant Health Solutions — a provider of solutions for behavioral health organizations — has entered into Arizona with a new addiction treatment pharmacy in Mesa.

Headquartered in Denver, Colorado, Cordant provides monitoring and risk assessment tools through its drug testing options and pharmacies, which specialize in the management and dispensing of addiction treatment medications. It also offers analytic tools and serves the criminal justice and pain management markets.

Cordant’s new Mesa location will focus on supporting clinicians that prescribe buprenorphine for medication-assisted treatment (MAT) of patients with opioid use disorder (OUD).

The company’s MAT pharmacy program currently serves eight states and about 5,800 patients. Normally, medication is delivered to clinicians’ offices or directly to patients’ homes. Cordant’s services have become even more important amid the pandemic, according to a press release announcing the news. 

“We started our MAT pharmacy program in 2019 because we saw a need to get buprenorphine to addiction treatment patients in a stigma-free way,” Sue Sommer, CEO and president of Cordant, said in the press release. “By partnering with in-office opioid addiction treatment facilities, we can deliver medication to patients at the time of their clinic visit, which removes barriers to obtaining the medication and has proven to help patients stay adherent to their treatment and potentially save lives.”

Companies featured in this article:

, ,